TreviPay Partners with Mirakl to Provide Invoicing and Payment Solutions to Marketplace Businesses
TreviPay, the global B2B payments and invoicing network, has partnered with Mirakl, the SaaS solution chosen by leading enterprises worldwide to manage their marketplace and dropship business, to provide a centralized financing, invoicing and payment solution for manufacturers, distributors and group purchasing organizations operating marketplace and dropship platforms powered by Mirakl globally.
Marketplace adoption is accelerating rapidly in the B2B space, with sales on B2B marketplaces doubled globally to $112 billion in 2022. As the number of B2B marketplaces continues to rise, they must offer better tools to stand out from the competition and attract and retain buyers and sellers. Digital-first B2B buyers expect flexible payment options with speed and convenience, while sellers need a digitized and streamlined accounts receivable process managed externally to provide efficiency and free up time and resources.
Through TreviPay, marketplace operators can offer consolidated invoicing, meaning if buyers shop from one or numerous merchants within the marketplace, they can receive a single consolidated invoice. Additionally, TreviPay will enable marketplace merchants to accept credit card payments and/or provide net terms invoicing (giving buyers the option to pay on invoice in 30, 60 or 90 days) while the merchant is paid immediately. Merchant payouts can be distributed to one or many bank accounts, and payments can also be split. Finally, TreviPay decisioning and onboarding make it simple for merchants to approve new buyers, and efficiently capture long-tail spend of smaller, infrequent purchasers. Rather than engaging multiple payments and invoicing vendors, TreviPay provides marketplaces and their merchants with the simplicity of a single partner.
“Marketplaces want to focus on creating dynamic communities for their buyers and sellers, not building out A/R departments to manage invoicing and payments – that’s where TreviPay comes in,” said Brandon Spear, CEO of TreviPay. “We know that loyalty begins with the payment in B2B marketplaces; buyers want credit decisions in less than 30 seconds and payments choice with options to meet their needs. And merchants need high approval rates to increase transaction volume, and they want to be paid immediately.”
“Successful B2B marketplaces offer a payments and invoicing experience that matches how buyers and sellers operate their businesses today,” said Andy Barker, Executive Vice President, Financial Services, Mirakl. “By partnering with TreviPay, Mirakl is expanding our ecosystem of proven partners to continue meeting the needs of enterprises across industries, so that every Mirakl-powered Marketplace can exceed the expectations of today’s digital-first B2B buyers.”
At the launch of this partnership, two joint enterprise clients have already signed on. To learn more about improving payments for B2B marketplaces, contact TreviPay or Mirakl today.
About TreviPay
At TreviPay, we believe loyalty begins with the payment. By understanding the diverse and unique requirements of B2B sellers, TreviPay’s global B2B payments and invoicing network enables enterprises to provide payments choice and convenience, open new markets and automate accounts receivables. With more than four decades of experience, TreviPay serves leaders looking to build loyalty while driving efficiency and embracing new digital channels, especially in industries with large distribution networks such as manufacturing, retail, and transportation. For more information, visit trevipay.com.
About Mirakl
Mirakl is the SaaS solution chosen by leading enterprises worldwide to manage their marketplace and dropship business. Mirakl’s intuitive, secure and scalable technology powers profitable digital growth in all angles of commerce – from platform models to personalization and payments. Platforms are the new competitive advantage in eCommerce, and market leaders like ABB, Astore by AccorHotels, Best Buy Canada, Carrefour, Catch, Changi Airport, The Kroger Co., Leroy Merlin, Macy's Inc., Maisons du Monde, and Toyota Material Handling, partner with Mirakl to win in the changing eCommerce landscape. For more information: www.mirakl.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230425005260/en/
Contact information
Alissa Clayton
The Fletcher Group
647.390.9085
alissa@fletchergroupllc.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval of ALYFTREK ™ , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 22:46:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non- F508del TRIKAFTA-Responsive Variants20.12.2024 22:35:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai
HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 21:32:00 EET | Press release
Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa
Aarhus University: New Global Study Sheds Light on the Learning Crisis: Three Years After COVID-1920.12.2024 14:00:00 EET | Press release
TIMSS 2023 has revealed an alarming global learning crisis exacerbated by the COVID-19 pandemic. Compared to the long term trend in progress in mathematics and science achievement has not only stalled but reversed when taking school closures into account, with the most vulnerable students facing the steepest losses. Key Findings Global Achievement Decline: A 0.11 standard deviation drop in student performance reflects the pandemic's lasting impact. Disproportionate Impact: Low performers, girls, and language minorities faced losses up to twice the average (0.22 standard deviations), deepening existing inequities. Regional Variations: Countries with prolonged school closures and limited remote learning resources experienced the steepest declines. Why This Matters School closures disrupted the education of over one billion children worldwide, with disadvantaged students suffering the most. “The widening gender gap in STEM fields is particularly troubling,” said Christian Kjeldsen, incomi
SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 14:00:00 EET | Press release
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom